Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilon Health, Inc. stock logo
AGL
Agilon Health
$1.24
+2.1%
$1.89
$0.71
$6.08
$511.81M0.147.23 million shs5.76 million shs
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$12.76
-2.0%
$12.42
$10.10
$20.72
$1.83BN/A403,393 shs287,031 shs
Celcuity, Inc. stock logo
CELC
Celcuity
$50.38
+3.3%
$24.67
$7.57
$53.85
$2.14B0.68590,561 shs1.36 million shs
Progyny, Inc. stock logo
PGNY
Progyny
$23.13
+2.5%
$22.47
$13.39
$26.76
$1.99B1.321.42 million shs815,204 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilon Health, Inc. stock logo
AGL
Agilon Health
-3.21%+15.87%-43.82%-45.48%-73.97%
Ardent Health, Inc. stock logo
ARDT
Ardent Health
+0.66%+2.89%+19.21%-12.09%-24.92%
Celcuity, Inc. stock logo
CELC
Celcuity
-0.91%-6.87%+260.19%+353.67%+186.21%
Progyny, Inc. stock logo
PGNY
Progyny
-0.79%-2.17%-1.66%+7.99%+7.12%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilon Health, Inc. stock logo
AGL
Agilon Health
2.6475 of 5 stars
4.12.00.00.02.90.00.6
Ardent Health, Inc. stock logo
ARDT
Ardent Health
3.1573 of 5 stars
3.40.00.00.02.00.03.1
Celcuity, Inc. stock logo
CELC
Celcuity
1.0085 of 5 stars
1.52.00.00.02.23.30.0
Progyny, Inc. stock logo
PGNY
Progyny
2.3908 of 5 stars
2.42.00.00.03.42.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilon Health, Inc. stock logo
AGL
Agilon Health
2.11
Hold$3.07148.70% Upside
Ardent Health, Inc. stock logo
ARDT
Ardent Health
2.70
Moderate Buy$19.5653.29% Upside
Celcuity, Inc. stock logo
CELC
Celcuity
3.00
Buy$50.600.44% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.73
Moderate Buy$25.108.52% Upside

Current Analyst Ratings Breakdown

Latest AGL, PGNY, CELC, and ARDT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2025
Agilon Health, Inc. stock logo
AGL
Agilon Health
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$4.00 ➝ $1.40
8/20/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$21.00 ➝ $23.00
8/18/2025
Celcuity, Inc. stock logo
CELC
Celcuity
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$50.00 ➝ $66.00
8/15/2025
Agilon Health, Inc. stock logo
AGL
Agilon Health
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$2.40 ➝ $1.10
8/15/2025
Celcuity, Inc. stock logo
CELC
Celcuity
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$74.00 ➝ $70.00
8/14/2025
Agilon Health, Inc. stock logo
AGL
Agilon Health
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$5.00 ➝ $1.00
8/11/2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $15.00
8/8/2025
Progyny, Inc. stock logo
PGNY
Progyny
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$28.00
8/8/2025
Progyny, Inc. stock logo
PGNY
Progyny
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$26.00 ➝ $28.00
8/7/2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$24.00 ➝ $20.00
8/6/2025
Agilon Health, Inc. stock logo
AGL
Agilon Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$3.00 ➝ $1.50
(Data available from 8/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilon Health, Inc. stock logo
AGL
Agilon Health
$6.06B0.08N/AN/A$0.99 per share1.25
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$5.97B0.31$2.51 per share5.09$11.52 per share1.11
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/A$1.05 per shareN/A
Progyny, Inc. stock logo
PGNY
Progyny
$1.17B1.70$0.35 per share65.89$5.99 per share3.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilon Health, Inc. stock logo
AGL
Agilon Health
-$260.15M-$0.77N/AN/AN/A-5.35%-66.76%-17.47%11/6/2025 (Estimated)
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$210.34M$1.817.056.515.714.11%16.66%5.18%11/5/2025 (Estimated)
Celcuity, Inc. stock logo
CELC
Celcuity
-$111.78M-$3.45N/AN/AN/AN/A-150.07%-64.67%N/A
Progyny, Inc. stock logo
PGNY
Progyny
$54.34M$0.5939.2035.581.864.28%10.69%7.12%N/A

Latest AGL, PGNY, CELC, and ARDT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Celcuity, Inc. stock logo
CELC
Celcuity
-$0.90-$1.04-$0.14-$1.04N/AN/A
8/7/2025Q2 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.42$0.19-$0.23$0.19$315.70 million$332.87 million
8/5/2025Q2 2025
Ardent Health, Inc. stock logo
ARDT
Ardent Health
$0.30$0.52+$0.22$0.52$1.54 billion$1.65 billion
8/4/2025Q2 2025
Agilon Health, Inc. stock logo
AGL
Agilon Health
-$0.11-$0.25-$0.14-$0.25$1.47 billion$1.39 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilon Health, Inc. stock logo
AGL
Agilon Health
N/AN/AN/AN/AN/A
Ardent Health, Inc. stock logo
ARDT
Ardent Health
N/AN/AN/AN/AN/A
Celcuity, Inc. stock logo
CELC
Celcuity
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilon Health, Inc. stock logo
AGL
Agilon Health
N/A
1.16
1.16
Ardent Health, Inc. stock logo
ARDT
Ardent Health
0.66
2.13
2.00
Celcuity, Inc. stock logo
CELC
Celcuity
2.24
4.58
6.61
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.70
2.70

Institutional Ownership

CompanyInstitutional Ownership
Agilon Health, Inc. stock logo
AGL
Agilon Health
N/A
Ardent Health, Inc. stock logo
ARDT
Ardent Health
N/A
Celcuity, Inc. stock logo
CELC
Celcuity
63.33%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%

Insider Ownership

CompanyInsider Ownership
Agilon Health, Inc. stock logo
AGL
Agilon Health
3.57%
Ardent Health, Inc. stock logo
ARDT
Ardent Health
1.70%
Celcuity, Inc. stock logo
CELC
Celcuity
15.77%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilon Health, Inc. stock logo
AGL
Agilon Health
1,076414.42 million399.63 millionNot Optionable
Ardent Health, Inc. stock logo
ARDT
Ardent Health
24,900143.11 million140.67 millionOptionable
Celcuity, Inc. stock logo
CELC
Celcuity
4042.43 million35.74 millionOptionable
Progyny, Inc. stock logo
PGNY
Progyny
31085.98 million77.90 millionOptionable

Recent News About These Companies

1 Russell 2000 Stock with Impressive Fundamentals and 2 We Ignore
Progyny, Inc. (NASDAQ:PGNY) Receives $24.90 Average PT from Brokerages
Progyny (PGNY) Stock Is Up, What You Need To Know
Truist Financial Remains a Hold on Progyny (PGNY)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilon Health stock logo

Agilon Health NYSE:AGL

$1.24 +0.03 (+2.07%)
Closing price 03:58 PM Eastern
Extended Trading
$1.22 -0.02 (-1.21%)
As of 05:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Ardent Health stock logo

Ardent Health NYSE:ARDT

$12.76 -0.26 (-2.00%)
Closing price 03:59 PM Eastern
Extended Trading
$12.46 -0.30 (-2.31%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.

Celcuity stock logo

Celcuity NASDAQ:CELC

$50.38 +1.61 (+3.30%)
Closing price 04:00 PM Eastern
Extended Trading
$50.44 +0.05 (+0.11%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Celcuity Inc., a clinical stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, advanced or metastatic breast cancer, and metastatic castration resistant prostate cancer. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. The company was founded in 2011 and is headquartered in Minneapolis, Minnesota.

Progyny stock logo

Progyny NASDAQ:PGNY

$23.13 +0.57 (+2.53%)
Closing price 04:00 PM Eastern
Extended Trading
$23.13 0.00 (0.00%)
As of 05:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.